Clinical Trials Browser

Phase 2 × Terminated × RFB4(dsFv)-PE38 recombinant immunotoxin × Clear all

NCT00924040 2015-10-29

Retreatment Protocol for BL22 Immunotherapy in Relapsed or Refractory Hairy Cell Leukemia

Phase 2 Terminated

1 enrolled 9 charts

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell